Raimar Löbenberg
Chairman chez DEFENCE THERAPEUTICS INC.
Fortune : 2 M $ au 31/03/2024
Profil
Raimar Löbenberg is the founder of RS Therapeutics, Inc. He currently holds the position of Chairman at Defence Therapeutics Inc and Independent Director at BioNxt Solutions, Inc. He is also the Co-Managing Director at Vektor Pharma TF GmbH.
In addition, he has been a Professor of Pharmacy & Pharmaceutical at the University of Alberta since 2000.
Previously, he served as the President of the Canadian Society for Pharmaceutical Sciences from 2014 to 2015.
Dr. Löbenberg obtained his doctorate degree from Johann Wolfgang Goethe-Universität Frankfurt am Main and his undergraduate degree from The Johannes Gutenberg University of Mainz.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
BIONXT SOLUTIONS INC
4,72% | 03/04/2023 | 5 000 000 ( 4,72% ) | 2 M $ | 31/03/2024 |
02/11/2023 | 100 000 ( 0,22% ) | 125 000 $ | 31/03/2024 |
Postes actifs de Raimar Löbenberg
Sociétés | Poste | Début |
---|---|---|
BIONXT SOLUTIONS INC. | Director/Board Member | 10/12/2018 |
DEFENCE THERAPEUTICS INC. | Chairman | 05/01/2021 |
University of Alberta | Corporate Officer/Principal | 01/01/2000 |
RS Therapeutics, Inc. | Founder | - |
Vektor Pharma TF GmbH
Vektor Pharma TF GmbH Pharmaceuticals: MajorHealth Technology Vektor Pharma TF GmbH engages in the development and production of transdermal systems. It is a narcotics company that focuses on the research, development and production of therapeutic films for pharmaceuticals, cosmetics and food. The firm offers formulation development, pharmaceutical analysis, machinery for development and production, and consultation products. The company was founded in 2009 and is headquartered in Uttenweiler, Germany. | Chief Executive Officer | - |
Anciens postes connus de Raimar Löbenberg
Sociétés | Poste | Fin |
---|---|---|
Canadian Society for Pharmaceutical Sciences | President | 01/01/2015 |
Formation de Raimar Löbenberg
Johann Wolfgang Goethe-Universität Frankfurt am Main | Doctorate Degree |
The Johannes Gutenberg University of Mainz | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
BIONXT SOLUTIONS INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Canadian Society for Pharmaceutical Sciences | |
RS Therapeutics, Inc. | |
Vektor Pharma TF GmbH
Vektor Pharma TF GmbH Pharmaceuticals: MajorHealth Technology Vektor Pharma TF GmbH engages in the development and production of transdermal systems. It is a narcotics company that focuses on the research, development and production of therapeutic films for pharmaceuticals, cosmetics and food. The firm offers formulation development, pharmaceutical analysis, machinery for development and production, and consultation products. The company was founded in 2009 and is headquartered in Uttenweiler, Germany. | Health Technology |
Defence Therapeutics Inc |